Kateřina Vávrová Selected Research

erythro-(2R,3S)-sphingosine

1/2019

Long and very long lamellar phases in model stratum corneum lipid membranes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kateřina Vávrová Research Topics

Disease

9	Atopic Dermatitis (Atopic Eczema) 01/2021 - 12/2013
6	Neoplasms (Cancer) 10/2018 - 12/2011
5	Skin Diseases (Skin Disease) 04/2020 - 12/2013
4	Adenocarcinoma 01/2018 - 01/2014
3	Leukemia 01/2018 - 01/2015
2	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2020 - 01/2017
1	beta-Thalassemia (Cooley's Anemia) 01/2022
1	Iron Overload 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Pain (Aches) 01/2021
1	X-Linked Ichthyosis (Ichthyosis, X Linked) 01/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2018
1	Necrosis 10/2016
1	Inflammation (Inflammations) 01/2016
1	Carcinoma (Carcinomatosis) 01/2015
1	Adenocarcinoma of Lung 01/2015
1	Cardiotoxicity 11/2011
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 10/2011

Drug/Important Bio-Agent (IBA)

7	IronIBA 01/2022 - 11/2011
6	LipidsIBA 01/2021 - 10/2016
5	CeramidesIBA 04/2020 - 12/2013
4	Chelating AgentsIBA 01/2022 - 11/2011
3	Filaggrin ProteinsIBA 01/2017 - 03/2014
2	Pharmaceutical PreparationsIBA 01/2021 - 04/2012
2	SphingosineIBA 01/2019 - 01/2017
2	CholesterolIBA 01/2019 - 10/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 09/2016
2	HydrazonesIBA 01/2014 - 10/2011
1	IonsIBA 01/2022
1	Flufenamic AcidIBA 01/2021
1	Diclofenac (SR 38)FDA LinkGeneric 01/2021
1	etofenamateIBA 01/2021
1	dihydroceramide desaturaseIBA 04/2020
1	Interleukin-6 (Interleukin 6)IBA 04/2020
1	CytokinesIBA 04/2020
1	Interleukin-8 (Interleukin 8)IBA 04/2020
1	erythro-(2R,3S)-sphingosineIBA 01/2019
1	SodiumIBA 01/2019
1	cholesteryl sulfateIBA 01/2019
1	GangliosidesIBA 10/2018
1	diphenyl (biphenyl)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 11/2017
1	SphingolipidsIBA 01/2017
1	3-ingenyl angelateIBA 10/2016
1	Phospholipids (Phosphatides)FDA LinkGeneric 10/2016
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2016
1	Nonesterified Fatty Acids (NEFA)IBA 11/2015
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2015
1	SemicarbazonesIBA 01/2015
1	LigandsIBA 01/2014
1	BromineIBA 01/2014
1	2-benzoylpyridineIBA 04/2012
1	ThiosemicarbazonesIBA 04/2012
1	Cathepsin DIBA 12/2011
1	Peptide Hydrolases (Proteases)FDA Link 12/2011
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 11/2011
1	Edetic Acid (EDTA)FDA Link 11/2011
1	CatecholaminesIBA 11/2011
1	Cardiotonic Agents (Cardiac Stimulants)IBA 11/2011
1	Dexrazoxane (Zinecard)FDA LinkGeneric 11/2011
1	AnthracyclinesIBA 11/2011
1	FluorineIBA 10/2011

Therapy/Procedure

2	Therapeutics 01/2016 - 11/2015